Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

InflaRx N.V. - Common Stock (NQ: IFRX )

2.000 -0.700 (-25.93%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about InflaRx N.V. - Common Stock

< Previous 1 2 3 4 Next >
Friday's session: top gainers and losers
Here are the top movers in Friday's session, showcasing the stocks with significant price changes. 
Via Chartmill
What's going on in today's session
Here are the top movers in Friday's session, showcasing the stocks with significant price changes. 
Via Chartmill
Friday's session: gap up and gap down stocks
The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
Top movers in Friday's pre-market session
Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
Earnings Preview: InflaRx
Via Benzinga
Earnings Preview: InflaRx
Via Benzinga
Get insights into the top gainers and losers of Thursday's after-hours session.
The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
IFRX Stock Earnings: InflaRx Misses EPS, Misses Revenue for Q2 2024
IFRX stock results show that InflaRx missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
IFRX Stock Earnings: InflaRx Beats EPS, Misses Revenue for Q1 2024
IFRX stock results show that InflaRx beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
IFRX Stock Earnings: InflaRx Misses EPS, Misses Revenue for Q4 2023
IFRX stock results show that InflaRx missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Why Tellurian Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Shares of Tellurian Inc. (NASDAQ: TELL) shares rose sharply in pre-market trading following a report suggesting the company hired Lazard to explore a possible sale. Tellurian shares jumped 16.3% to... 
Via Benzinga
Why InflaRx Stock Skyrocketed This Week
The biopharmaceutical company's near-term sales outlook has gotten a huge boost following Emergency Use Authorization for one of its drugs. 
Via The Motley Fool
Analyst Expectations for InflaRx's Future
Via Benzinga
Earnings Scheduled For March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. 
Via Benzinga
InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients
From InflaRx N.V.
Via GlobeNewswire
Why Shares of InflaRx Are Soaring Wednesday
A key EUA from the FDA for the company's COVID-19 therapy gave the stock a jolt. 
Via The Motley Fool
Why DigitalOcean Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Gainers Altamira Therapeutics Ltd (NASDAQ: CYTO) shares surged 54.1% to $0.25 in pre-market trading after gaining 5% on Thursday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to dive into the biggest pre-market stock movers for Friday with all the shares investors will want to keep an eye on today! 
Via InvestorPlace
Why Oncorus Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket
Gainers Auddia Inc. (NASDAQ: AUUD) shares rose 103.2% to $0.8809 in pre-market trading after gaining around 9% on Friday. 
Via Benzinga
The Week In Charts: 0DTE Options - Too Good To Be True?
Zero-days; how Core Methodology can be used in Crypto, with current Crypto and stock market conditions; favorite stock picks. 
Via Talk Markets
Apogee Enterprises, Sportsman's Warehouse And 3 Stocks To Watch Heading Into Wednesday
With US futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Post-Pandemic Potential: Analysts Eye InflaRx COVID-19 Antibody For Market Breakthrough
Via Benzinga
Walmart To Rally 14%? Here Are 10 Other Analyst Forecasts For Thursday
Keybanc boosted the price target for Walmart Inc. (NYSE: WMT) from $165 to $170. Keybanc analyst Bradley Thomas maintained an Overweight rating on the stock. Walmart shares fell 0.2% to $149.37 in... 
Via Benzinga
Dow Rises 80 Points; MarketAxess Holdings Shares Slide
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 80 points on Wednesday. The Dow traded up 0.24% to 33,482.53 while the NASDAQ fell 1.21% to 11,979.98. The S&P 500,... 
Via Benzinga
Stocks Mixed As Investors Continue To Weigh Jobs Data
The Dow Jones Industrial Average has made its way into positive territory midday, though the S&P 500 Index and Nasdaq Composite are still swimming in the red. 
Via Talk Markets
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite... 
Via Benzinga
Inflarx NV (NASDAQ: IFRX) is One of Wednesday Morning’s Most Active Stocks
Via Investor Brand Network
Nasdaq Tumbles 150 Points; Liminal BioSciences Shares Spike Higher
U.S. stocks traded mostly lower midway through trading, with the Nasdaq Composite dropping around 150 points on Wednesday. The Dow traded up 0.07% to 33,425.80 while the NASDAQ fell 1.27% to 11,972.78.... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 5, 2023
Via Benzinga
Why Is Liminal Biosciences (LMNL) Stock Up 77% Today?
Liminal Biosciences (LMNL) stock is taking off on Wednesday as investors react to the company getting an unsolicited transaction proposal. 
Via InvestorPlace
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.